Table 21.
A | B | Agree | A+/B− | A−/B+ |
---|---|---|---|---|
HRSD17 | QIDS-IVR16 | 88.1% | 6.1% | 5.9% |
HRSD17 | QIDS-C16 | 91.2% | 4.6% | 4.2% |
HRSD17 | QIDS-SR16 | 83.5% | 6.7% | 9.8% |
QIDS-IVR16 | QIDS-C16 | 88.1% | 6.1% | 5.9% |
QIDS-IVR16 | QIDS-SR16 | 85.0% | 5.9% | 9.2% |
QIDS-C16 | QIDS-SR16 | 86.0% | 5.2% | 8.8% |
Remission was HRSD17 <7; QIDS-C16 <5; QIDS-SR16 <5; QIDS-IVR16 <6.